“Long-Term Improvements in Health-Related Quality of Life of Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s20. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1173.